Prediabetes — Practical Prevention
Clear, appointment-ready steps to stop prediabetes from becoming type 2 diabetes. Built around the strongest evidence first (DPP lifestyle), with transparent add-ons when appropriate.
What counts as prediabetes
If your results land in these ranges, you're in the high-risk zone — not diabetes yet, but higher odds of progressing without action.
| Test | Prediabetes range | Diabetes range |
|---|---|---|
| A1c | 5.7–6.4% | ≥ 6.5% |
| Fasting plasma glucose | 100–125 mg/dL (5.6–6.9 mmol/L) | ≥ 126 mg/dL (7.0 mmol/L) |
| 2-hour OGTT (75 g) | 140–199 mg/dL (7.8–11.0 mmol/L) | ≥ 200 mg/dL (11.1 mmol/L) |
Source: ADA diagnostic criteria
What to measure — and why
Prediabetes is a cardiometabolic risk flag, not just a glucose number. These are the baseline checks worth discussing with your clinician.
At-home / in-clinic
- Blood pressure: aim for <120/<80 in-office; if home average is around ≥135/85, flag it with your clinician. ACC/AHA
- Waist circumference: a useful marker of visceral fat risk — track over time.
- Weight trend: weekly average beats daily noise.
Metabolic syndrome markers
These are common cut points used to flag insulin resistance risk (3 of 5 = metabolic syndrome). Waist cut points can differ by ethnicity.
| Marker | Common cut point |
|---|---|
| Waist circumference | ≥102 cm (40 in) men; ≥88–89 cm (35 in) women |
| Triglycerides | ≥150 mg/dL (1.7 mmol/L) or on treatment |
| HDL | <40 mg/dL men; <50 mg/dL women or on treatment |
| Blood pressure | ≥130/85 mmHg or on treatment |
| Fasting glucose | ≥100 mg/dL or on treatment |
Labs to discuss with your clinician
- A1c and/or fasting glucose (and OGTT if unclear).
- Lipids: LDL-C, HDL-C, triglycerides, non-HDL; consider ApoB and a one-time Lp(a) depending on your risk profile.
- Liver enzymes (ALT/AST): fatty liver is common with insulin resistance.
- Kidney basics: creatinine/eGFR and urine albumin-to-creatinine ratio if clinically indicated.
- Optional: thyroid, ferritin/iron, B12 (especially if considering metformin long-term), sleep apnea screening if symptomatic.
Simple, high-ROI 30-day plan
Week 1 — set the environment
- Pick one tracking method: weight trend or waist circumference or step count. One is enough.
- Walk after meals: start with 10 minutes after your biggest meal.
- Build your default breakfast (protein + fiber): eggs + fruit + yogurt; tofu scramble; Greek yogurt + berries + nuts; etc.
Week 2 — lock in movement
- 150 minutes/week of moderate movement (e.g., 30 min × 5 days).
- Strength 2×/week — full body: squat, hinge, push, pull, carry patterns.
Week 3 — upgrade your plate
- Half the plate non-starchy veg at most meals.
- Protein first — 25–35 g per meal is a practical target for many adults.
- Swap liquid calories (juice/soda) for water, sparkling, or unsweetened options.
Week 4 — make it stick
- Enroll in a recognized Diabetes Prevention Program if available (in-person or virtual). CDC DPP
- Decide your follow-up: re-check A1c/fasting glucose in ~3 months is common — confirm with your clinician.
Food rules that actually work (no diet cults)
1. Build meals around protein + fiber
- Protein: fish, eggs, poultry, tofu/tempeh, beans/lentils, Greek yogurt
- Fiber: veg, legumes, whole grains you tolerate, chia/flax, berries
- Carbs: you don't have to "ban" them — choose slower carbs and match them to movement.
2. Use the carb timing trick
- Put most starchier carbs after exercise or earlier in the day.
- If a meal is carb-heavy, commit to a 10–20 min walk afterward.
3. Cut the obvious accelerants
- Sugary drinks — fastest way to spike glucose
- Ultra-processed snack loops — chips/cookies/candy as default
- Alcohol — often sabotages sleep and appetite regulation
Exercise — the cheat codes
Post-meal walking: tiny habit, big effect
- Walking has a greater acute benefit on post-meal glucose when done as soon as possible after eating vs before or later. Engeroff 2023 review
- Even a single 30-minute brisk post-meal walk improves glycemic response. PMID: 35268055
Strength training: insulin sensitivity loves muscle
- Start with 2 sessions/week, full body. Add a third if you recover well.
- Progress slowly — consistency beats intensity spikes.
The DPP target (still the gold standard)
- ≥150 min/week moderate activity — brisk walking is the model example. CDC
Medications — when lifestyle isn't enough, or risk is higher
Metformin (the classic)
- In the original DPP trial, metformin reduced diabetes incidence by 31% vs placebo — but lifestyle was stronger (58%). PMID: 11832527
- Guidelines commonly suggest considering metformin for higher-risk prediabetes (younger age, higher BMI, history of gestational diabetes). ADA 2026
- Practical notes: GI side effects are common early; extended-release often helps. Long-term use can lower B12 in some people — ask about monitoring.
Anti-obesity medications
Supplements — transparent take
Lifestyle is the cornerstone. Supplements are "maybe helpful" add-ons — and only some have decent evidence. Never use as your main strategy.
| Supplement | What the evidence suggests | Typical studied doses | Key cautions |
|---|---|---|---|
| Cinnamon | RCTs in prediabetes show improvements in fasting glucose/glucose tolerance over ~12 weeks. PMID: 33123653 A 2024 crossover CGM trial suggests improved glucose control in obesity-related prediabetes. PMID: 38290699 | Commonly ~1.5–4 g/day (often divided) | Coumarin content varies (cassia has more). Discuss if liver disease or anticoagulants. |
| Vitamin D | D2d RCT: D3 4000 IU/day did not significantly reduce diabetes incidence overall. PMID: 31173679 IPD meta-analysis of 3 trials found modest ~15% risk reduction. PMID: 36745886 | 4000 IU/day or 20,000 IU/week (in trials, under monitoring) | Best value is correcting deficiency. Avoid high doses without monitoring (kidney stone risk). |
| Magnesium | Meta-analyses suggest improved insulin sensitivity markers, especially with ≥4 months duration — results are mixed. PMID: 27329332 | 200–400 mg/day elemental magnesium | Diarrhea common with oxide form; consider glycinate/citrate. Avoid high doses in kidney disease. |
| Berberine | Evidence is strongest in T2D/metabolic syndrome; not first-line for prevention. PMID: 36467075 | Commonly 500 mg, 2–3×/day with meals | Drug interactions matter. Avoid in pregnancy/breastfeeding unless advised. |
What to track and when
Pick 1–2 metrics to track
- Weekly weight average (trend over time)
- Waist circumference (monthly)
- Steps or minutes walked after meals
When to re-check labs
- Common practice: repeat A1c/fasting glucose in ~3 months after meaningful lifestyle changes. Confirm timing with your clinician.
- ADA: people with prediabetes (A1c ≥5.7% or IGT/IFG) should generally be tested yearly. ADA Standards of Care 2026
Receipts
- ADA diagnostic criteria (A1c/FPG/OGTT). Link
- USPSTF screening recommendation (2021). Link
- DPP trial — NEJM 2002. PMID: 11832527
- CDC National DPP overview. Link
- Post-meal exercise timing review (Engeroff 2023). PMC10036272
- Vitamin D — D2d RCT. PMID: 31173679
- Vitamin D — IPD meta-analysis. PMID: 36745886
- Cinnamon trial in prediabetes. PMID: 33123653
- Cinnamon CGM crossover trial. PMID: 38290699
- Magnesium meta-analysis (HOMA-IR, fasting glucose). PMID: 27329332
- Berberine meta-analysis (T2D). PMID: 36467075
- NHLBI metabolic syndrome diagnosis. NHLBI
- ADA 2026 — Prevention/Delay of Diabetes. Link
- ADA Standards of Care 2026 — Diagnosis. PMC12690183